Vimarsana
Biggest News Aggregation in the World

Page 2 - Tom Mander News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tom Mander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tom Mander Today - Breaking & Trending Today

Domainex secures a prestigious King's Award for Enterprise - Vimarsana News

Domainex secures a prestigious King's Award for Enterprise

Cambridge and Saffron Walden, UK, 21st April 2023 / Sciad Newswire / Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises the company’s outstanding growth in international trade over three years (2019-2021) which amounted to a mor...

Black Country mental health charity receives funding boost - Vimarsana News

Black Country mental health charity receives funding boost

A BLACK Country charity that supports men with their mental health has received a funding boost thanks to a big-hearted borough business.

Black Country mental health charity receives funding boost - Vimarsana News

Black Country mental health charity receives funding boost

A BLACK Country charity that supports men with their mental health has received a funding boost thanks to a big-hearted borough business.

Amphista partners with Domainex to advance drug portfolio - Vimarsana News

Amphista partners with Domainex to advance drug portfolio

Partnership will maximise the chance of successfully progressing its research projects - News - PharmaTimes

Anti-inflammatory drug candidate DMXD-011 shows efficacy in ex-vivo human studies - Vimarsana News

Anti-inflammatory drug candidate DMXD-011 shows efficacy in ex-vivo human studies

Cambridge, UK, 14th September 2022 / Sciad Newswire / Domainex Ltd., based in Cambridge UK, is a leading provider of integrated drug discovery services. As a result of the work carried out by Domainex during an in-house research programme to identify inhibitors of protein kinases TBK1 and IKK-epsilon, DMXD-011 has b...